Stay updated on Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check9 days agoChange DetectedA site-wide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.6%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the study record history remains unchanged.SummaryDifference0.1%

- Check23 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the entry for v3.6.6 was removed from the history.SummaryDifference0.1%

- Check65 days agoChange DetectedNew revision v3.6.6 has been added to the study's history, and the previous revision v3.6.5 has been removed. This reflects a minor update to the revision tracking for this record rather than changes to the trial data or public-facing content.SummaryDifference0.1%

Stay in the know with updates to Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.